A Novel 3D-Printed Strut-Type Prosthesis Reconstructs the Hemicortical Defect After Distal Femur Parosteal Osteosarcoma Resection: The Mid-Term Follow-Up Outcome

Jianhua Mu , Yitian Wang , Han Liu , Xuanhong He , Zhuangzhuang Li , Minxun Lu , Fan Tang , Yi Luo , Yong Zhou , Li Min , Chongqi Tu

Orthopaedic Surgery ›› 2026, Vol. 18 ›› Issue (8) : 1668 -1678.

PDF (1146KB)
Orthopaedic Surgery ›› 2026, Vol. 18 ›› Issue (8) :1668 -1678. DOI: 10.1111/os.70360
RESEARCH ARTICLE
A Novel 3D-Printed Strut-Type Prosthesis Reconstructs the Hemicortical Defect After Distal Femur Parosteal Osteosarcoma Resection: The Mid-Term Follow-Up Outcome
Author information +
History +
PDF (1146KB)

Abstract

Background: Parosteal osteosarcoma (PAOS) is a rare and low-grade primary bone malignant tumor that typically occurs in the distal femur. Traditional reconstruction options for distal femur PAOS include distal femoral replacement (DFR), autografts, and allografts, but issues such as functional sacrifice, insufficient mechanical strength, and low bone union rate limit their further clinical application. 3D-printed prosthesis, due to the matching shape of various bone defects, could be a novel strategy to reconstruct the hemicortical defect after distal femur PAOS tumor resection. In this study, we designed a 3D-printed strut-type prosthesis (3DPSP) to repair the hemicortical defect and evaluated the mid-term effect in distal femur PAOS.

Methods: A retrospective analysis was conducted on patients diagnosed with PAOS at the distal femur between April 2018 and January 2021. Six patients received DFR and six patients received customized 3DPSP reconstruction. Clinical outcomes including oncology status, defect lengths, and ranges of motion of the knee, Musculoskeletal Tumor Society (MSTS) scores, and complications were recorded. X-ray was performed to evaluate the position and stability of the prosthesis and T-SMART was applied to assess the interface osteointegration between prosthesis and bone.

Results: A total of 12 patients were enrolled in this study with an average follow-up of 42.1 ± 11.8 months, ranging from 22 to 59 months. In the 3DPSP group, the average operation time was 2.3 ± 0.4 h; the intraoperative blood loss was 175.0 ± 82.2 mL. The average range of motion of the knee was 0°–123° and the mean MSTS score was 28.3 ± 1.6. Compared to the DFR group, the 3DPSP group exhibited significantly less intraoperative blood loss and superior functional recovery.

Conclusions: In this study, we designed a novel 3DPSP to reconstruct the hemicortical defect after distal femur PAOS resection. The mid-term follow-up result demonstrated that this prosthesis could be an effective reconstruction option for distal femur PAOS patients because of the restored limb function and favorable bone-prosthesis integration. Further observation of this novel prosthesis is needed.

Keywords

3D-printed prosthesis / hemicortical resection / metaphysis of the distal femur / parosteal osteosarcoma / reconstruction

Cite this article

Download citation ▾
Jianhua Mu, Yitian Wang, Han Liu, Xuanhong He, Zhuangzhuang Li, Minxun Lu, Fan Tang, Yi Luo, Yong Zhou, Li Min, Chongqi Tu. A Novel 3D-Printed Strut-Type Prosthesis Reconstructs the Hemicortical Defect After Distal Femur Parosteal Osteosarcoma Resection: The Mid-Term Follow-Up Outcome. Orthopaedic Surgery, 2026, 18 (8) : 1668-1678 DOI:10.1111/os.70360

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

J. F. Sinovic, J. A. Bridge, and J. R. Neff, “Ring Chromosome in Parosteal Osteosarcoma. Clinical and Diagnostic Significance,” Cancer Genetics and Cytogenetics 62 (1992): 50–52.

[2]

V. S. Kumar, N. Barwar, and S. A. Khan, “Surface Osteosarcomas: Diagnosis, Treatment and Outcome,” Indian Journal of Orthopaedics 48 (2014): 255–261.

[3]

O. Savvidou, O. Papakonstantinou, E. Lakiotaki, et al., “Surface Bone Sarcomas: An Update on Current Clinicopathological Diagnosis and Treatment,” EFORT Open Reviews 6 (2021): 905–917.

[4]

K. Okada, F. J. Frassica, F. H. Sim, J. W. Beabout, J. R. Bond, and K. K. Unni, “Parosteal Osteosarcoma. A Clinicopathological Study,” Journal of Bone and Joint Surgery. American Volume 76 (1994): 366–378.

[5]

K. Harper, P. Sathiadoss, A. Saifuddin, and A. Sheikh, “A Review of Imaging of Surface Sarcomas of Bone,” Skeletal Radiology 50 (2021): 9–28.

[6]

O. D. Savvidou, S. Goumenos, I. Trikoupis, et al., “Oncological and Functional Outcomes After Hemicortical Resection and Biological Reconstruction Using Allograft for Parosteal Osteosarcoma of the Distal Femur,” Sarcoma 2022 (2022): 5153924.

[7]

B. K. Wilke, A. R. Cooper, C. P. Gibbs, M. T. Scarborough, and A. R. Spiguel, “Long-Term Functional Outcomes of Distal Femoral Replacements Compared to Geographic Resections for Parosteal Osteosarcomas of the Distal Femur,” Iowa Orthopaedic Journal 38 (2018): 177–181.

[8]

A. Shehadeh, J. Noveau, M. Malawer, and R. Henshaw, “Late Complications and Survival of Endoprosthetic Reconstruction After Resection of Bone Tumors,” Clinical Orthopaedics and Related Research 468 (2010): 2885–2895.

[9]

P. T. Funovics, F. Bucher, C. D. Toma, R. I. Kotz, and M. Dominkus, “Treatment and Outcome of Parosteal Osteosarcoma: Biological Versus Endoprosthetic Reconstruction,” Journal of Surgical Oncology 103 (2011): 782–789.

[10]

S. Y. Lee, D. G. Jeon, W. H. Cho, W. S. Song, and B. S. Kim, “Are Pasteurized Autografts Durable for Reconstructions After Bone Tumor Resections?,” Clinical Orthopaedics and Related Research 476 (2018): 1728–1737.

[11]

W. M. Chen, P. K. Wu, C. F. Chen, L. H. Chung, C. L. Liu, and T. H. Chen, “High-Grade Osteosarcoma Treated With Hemicortical Resection and Biological Reconstruction,” Journal of Surgical Oncology 105 (2012): 825–829.

[12]

G. H. Kim and T. G. Cho, “A Comparative Study on the Treatment of Osteoporotic Vertebral Compression Fractures With Early Ambulation and at Least 1 Week of Absolute Bed Rest,” Korean Journal of Neurotrauma 18, no. 1 (2022): 56–63.

[13]

Y. Wu, J. Liu, L. Kang, et al., “An Overview of 3D Printed Metal Implants in Orthopedic Applications: Present and Future Perspectives,” Heliyon 9, no. 7 (2023): e17718.

[14]

X. Wang, S. Xu, S. Zhou, et al., “Topological Design and Additive Manufacturing of Porous Metals for Bone Scaffolds and Orthopaedic Implants: A Review,” Biomaterials 83 (2016): 127–141.

[15]

F. S. L. Bobbert, K. Lietaert, A. A. Eftekhari, et al., “Additively Manufactured Metallic Porous Biomaterials Based on Minimal Surfaces: A Unique Combination of Topological, Mechanical, and Mass Transport Properties,” Acta Biomaterialia 53 (2017): 572–584.

[16]

D. Carluccio, C. Xu, J. Venezuela, et al., “Additively Manufactured Iron-Manganese for Biodegradable Porous Load-Bearing Bone Scaffold Applications,” Acta Biomaterialia 103 (2020): 346–360.

[17]

C. N. Kelly, T. Wang, J. Crowley, et al., “High-Strength, Porous Additively Manufactured Implants With Optimized Mechanical Osseointegration,” Biomaterials 279 (2021): 121206.

[18]

D. Melancon, Z. S. Bagheri, R. B. Johnston, L. Liu, M. Tanzer, and D. Pasini, “Mechanical Characterization of Structurally Porous Biomaterials Built via Additive Manufacturing: Experiments, Predictive Models, and Design Maps for Load-Bearing Bone Replacement Implants,” Acta Biomaterialia 63 (2017): 350–368.

[19]

Y. Qin, A. Liu, H. Guo, et al., “Additive Manufacturing of Zn-Mg Alloy Porous Scaffolds With Enhanced Osseointegration: In Vitro and In Vivo Studies,” Acta Biomaterialia 145 (2022): 403–415.

[20]

Z. Wang, M. Zhang, Z. Liu, et al., “Biomimetic Design Strategy of Complex Porous Structure Based on 3D Printing Ti-6Al-4V Scaffolds for Enhanced Osseointegration,” Materials & Design 218 (2022): 110721.

[21]

B. Ren, Y. Wan, C. Liu, et al., “Improved Osseointegration of 3D Printed Ti-6Al-4V Implant With a Hierarchical Micro/Nano Surface Topography: An In Vitro and In Vivo Study,” Materials Science and Engineering: C 118 (2021): 111505.

[22]

M. P. Bus, J. A. Bramer, G. R. Schaap, et al., “Hemicortical Resection and Inlay Allograft Reconstruction for Primary Bone Tumors: A Retrospective Evaluation in The Netherlands and Review of the Literature,” Journal of Bone and Joint Surgery. American Volume 9, no. 97 (2015): 738–750.

[23]

Y. Kim, W. H. Cho, D. G. Jeon, M. S. Kim, and W. S. Song, “The Clinical Outcome of Hemicortical Resection in Extremity Malignant Bone Tumors,” Journal of Surgical Oncology 125, no. 5 (2022): 924–932.

[24]

M. R. Gonzalez, E. Okay, J. O. Werenski, et al., “What Are the Long-Term Clinical and Functional Outcomes After Hemicortical Allograft Reconstruction for Primary Bone Tumors?,” Journal of Surgical Oncology 131, no. 8 (2025): 1670–1678.

[25]

V. O. Lewis, M. C. Gebhardt, and D. S. Springfield, “Parosteal Osteosarcoma of the Posterior Aspect of the Distal Part of the Femur. Oncological and Functional Results Following a New Resection Technique,” Journal of Bone and Joint Surgery. American Volume 82, no. 8 (2000): 1083–1088.

[26]

T. Liu, Z. Y. Liu, Q. Zhang, and X. S. Zhang, “Hemicortical Resection and Reconstruction Using Pasteurised Autograft for Parosteal Osteosarcoma of the Distal Femur,” Bone & Joint Journal 95-b, no. 9 (2013): 1275–1279.

[27]

M. Agarwal, A. Puri, C. Anchan, M. Shah, and N. Jambhekar, “Hemicortical Excision for Low-Grade Selected Surface Sarcomas of Bone,” Clinical Orthopaedics and Related Research 459 (2007): 161–166.

[28]

H. Wu, S. Yang, J. Liu, et al., “3D Printing Guide Plate for Accurate Hemicortical Bone Tumor Resection in Metaphysis of Distal Femoral: A Technical Note,” Journal of Orthopaedic Surgery and Research 16, no. 1 (2021): 343.

[29]

Q. Zhang, T. Liu, X. Guo, and L. Ling, “Salvage Therapy by Hemicortical Excision and Reconstruction for Low-Grade Malignant Bone Tumour,” Zhong Nan Da Xue Xue Bao. Yi Xue Ban 38, no. 7 (2013): 691–694.

[30]

C. Torres-Sanchez, F. R. A. Al Mushref, M. Norrito, K. Yendall, Y. Liu, and P. P. Conway, “The Effect of Pore Size and Porosity on Mechanical Properties and Biological Response of Porous Titanium Scaffolds,” Materials Science & Engineering, C: Materials for Biological Applications 77 (2017): 219–228.

[31]

R. S. Avedian, R. C. Haydon, and T. D. Peabody, “Multiplanar Osteotomy With Limited Wide Margins: A Tissue Preserving Surgical Technique for High-Grade Bone Sarcomas,” Clinical Orthopaedics and Related Research 10, no. 468 (2010): 2754–2764.

[32]

A. Benady, J. S. Meyer, Y. Ran, et al., “Intercalary and Geographic Lower Limb Tumor Resections With the Use of 3D Printed Patient Specific Instruments- When Less Is More,” Journal of Orthopaedics 32 (2022): 36–42.

[33]

Z. Guo, R. Zhang, Y. Que, B. Hu, S. Xu, and Y. Hu, “Case Report: 3D-Printed Prosthesis for Limb Salvage and Joint Preservation After Tibial Sarcoma Resection,” Frontiers in Surgery 9 (2022): 873272.

[34]

M. Lu, Y. Li, Y. Luo, W. Zhang, Y. Zhou, and C. Tu, “Uncemented Three-Dimensional-Printed Prosthetic Reconstruction for Massive Bone Defects of the Proximal Tibia,” World Journal of Surgical Oncology 16, no. 1 (2018): 47.

[35]

L. Min, Y. Zhou, F. Tang, et al., “Reconstruction With Scapular Hemiarthroplasty Endoprosthesis After Scapulectomy for Malignant Tumour,” International Orthopaedics 41, no. 5 (2017): 1057–1063.

[36]

T. Gong, Y. Luo, M. Lu, et al., “The Optimal Strategy for 3D-Printed Uncemented Endoprosthesis for the Bone Defect Reconstruction of the Distal Radius, Based on Biomechanical Analysis and Retrospective Cohort Study,” Journal of Surgical Oncology 127, no. 6 (2023): 1043–1053.

[37]

C. Zoccali, J. Baldi, D. Attala, et al., “3D-Printed Titanium Custom-Made Prostheses in Reconstruction After Pelvic Tumor Resection: Indications and Results in a Series of 14 Patients at 42 Months of Average Follow-Up,” Journal of Clinical Medicine 10, no. 16 (2021): 3539.

[38]

X. Li, T. Ji, S. Huang, C. Wang, Y. Zheng, and W. Guo, “Biomechanics Study of a 3D Printed Sacroiliac Joint Fixed Modular Hemipelvic Endoprosthesis,” Clinical Biomechanics 74 (2020): 87–95.

Rights & permissions

2026 The Author(s). Orthopaedic Surgery published by Tianjin Hospital and John Wiley & Sons Australia, Ltd.

PDF (1146KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/

〈 〉